What is NDC 60505-0033?

60505-0033 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pentoxifylline?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pentoxifylline NDC 60505-0033 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-0033Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-0033Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-0033-6	60505003306	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-6)Marketed from Jun 10, 1999
60505-0033-7	60505003307	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-7)Marketed from Jun 10, 1999

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pentoxifylline
Generic name (nonproprietary): pentoxifylline
Active ingredients: Pentoxifylline — 400 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075191
Marketing start: Jun 10, 1999
Listing expires: Dec 31, 2027
Other FDA classes: Hematologic Activity Alteration (Physiologic effect)
Identifiers: Product ID 60505-0033_8ebb3bcf-3415-64a7-4b78-f94ee3fb9470SPL ID 8ebb3bcf-3415-64a7-4b78-f94ee3fb9470
Pharmacologic class: Blood Viscosity Reducer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505003306 followed by a unit qualifier and the quantity

Package 60505-0033-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60505-0033

What is NDC 60505-0033?: 60505-0033 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pentoxifylline.
What is the active ingredient?: Pentoxifylline.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pentoxifylline?: 6 other product NDCs are listed under this name. See all Pentoxifylline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pentoxifylline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-856	16571-0856-0116571-0856-0516571-0856-11+2 more
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2586	71335-2586-0171335-2586-0271335-2586-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	ANI Pharmaceuticals, Inc.	70954-668	70954-0668-1070954-0668-20
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8511	00615-8511-39
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910	63629-2910-0163629-2910-0263629-2910-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-5448	00904-5448-61

Other NDCs under ANDA 075191

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075191
Product	Strength	Form · route	Labeler	Product NDC
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-5448